Published in Acta Neuropathol on January 01, 1992
Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol (2007) 2.65
Senile plaques in temporal lobe epilepsy. Acta Neuropathol (1994) 1.44
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol (2001) 1.20
Evidence for the experimental transmission of cerebral beta-amyloidosis to primates. Int J Exp Pathol (1993) 1.10
Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system. Brain Struct Funct (2009) 0.97
Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer's disease. Acta Neuropathol Commun (2013) 0.80
Interaction between prion protein and Aβ amyloid fibrils revisited. ACS Chem Neurosci (2014) 0.78
AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease. Mol Ther (2015) 0.77
Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science (1990) 4.91
A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology (1988) 3.28
Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med (1989) 3.24
Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science (1990) 3.10
Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science (1987) 3.07
Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry (1988) 3.04
Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A (1988) 2.95
Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry (1990) 2.91
Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr (1987) 2.80
Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett (1989) 2.69
Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol (1989) 2.61
Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology (1990) 2.36
Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J (1988) 2.26
Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals. Neurosci Lett (1988) 2.26
The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol (1990) 2.23
The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J Neurol Sci (1989) 1.95
Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron (1989) 1.59
A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol Appl Neurobiol (1990) 1.53
Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science (1988) 1.51
Immunocytochemical localization of the precursor protein for beta-amyloid in the rat central nervous system. Neuron (1988) 1.40
Progressive aphasia: a precursor of global dementia? Neurology (1990) 1.36
Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease beta-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am J Pathol (1989) 1.24
Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol (1990) 1.15
Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science (1990) 1.15
Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains. Lab Invest (1989) 1.13
Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol Aging (1989) 1.12
Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains. Proc Natl Acad Sci U S A (1989) 1.04
Widespread expression of amyloid beta-protein precursor gene in rat brain. Am J Pathol (1989) 1.03
An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Neuropathol Appl Neurobiol (1989) 0.99
The amyloid beta-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res (1990) 0.92
Deposition of amyloid (A4) protein within the brains of persons with dementing disorders other than Alzheimer's disease and Down's syndrome. Neurosci Lett (1990) 0.91
Alzheimer's disease. The commonest form of amyloidosis. Arch Pathol Lab Med (1983) 0.90
Antibodies raised against different portions of A4 protein identify a subset of plaques in Down's syndrome. Neurosci Lett (1990) 0.85
The molecular and cellular pathology of Alzheimer neurofibrillary lesions. J Gerontol (1989) 0.78
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
CONTROL OF GRAM-NEGATIVE BACTERIA IN EXPERIMENTAL ANIMALS BY STREPTOMYCIN. Science (1944) 11.30
Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med (2011) 7.89
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A (1998) 7.69
Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication. Microbiol Rev (1981) 6.91
POSSUM: a scoring system for surgical audit. Br J Surg (1991) 6.05
Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest (1975) 5.72
CAFASP-1: critical assessment of fully automated structure prediction methods. Proteins (1999) 5.54
An integrated nanoliter DNA analysis device. Science (1998) 5.40
Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med (1998) 5.16
Breaking down language barriers. The NHS needs to provide accessible interpreting services for all. BMJ (1998) 5.09
Quality of life measures in health care. I: Applications and issues in assessment. BMJ (1992) 4.53
The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity (1999) 4.24
A SEARCH FOR VIRUS-INACTIVATING SUBSTANCES AMONG MICROORGANISMS. Science (1945) 3.86
Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry (2007) 3.60
Genome-wide survey of protein kinases required for cell cycle progression. Nature (2004) 3.40
Statistical shape analysis of neuroanatomical structures based on medial models. Med Image Anal (2003) 3.17
Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry (1988) 3.04
The glucan components of the cell wall of baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure. Biochem J (1969) 3.02
Temporal and spatial expression patterns of the small heat shock (hsp16) genes in transgenic Caenorhabditis elegans. Mol Biol Cell (1992) 2.98
Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry (1990) 2.91
Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology (1993) 2.79
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res (1999) 2.75
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia (2006) 2.66
Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril (1998) 2.57
Neonatal detection of developmental dysplasia of the hip (DDH) J Bone Joint Surg Br (1998) 2.56
Behavioral changes in Huntington Disease. Neuropsychiatry Neuropsychol Behav Neurol (2001) 2.52
Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry (2001) 2.50
Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals. J Clin Microbiol (1981) 2.39
The TAPS project. 6: New long-stay psychiatric patients and social deprivation. Br J Psychiatry (1992) 2.29
Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ (1992) 2.28
The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease. Acta Neuropathol (1990) 2.23
Predicting the one-year course of adolescent major depression. J Am Acad Child Adolesc Psychiatry (1995) 2.20
Genetic transfer and bacterial taxonomy. Bacteriol Rev (1970) 2.10
Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis. Clin Infect Dis (2000) 2.08
High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice. Nat Biotechnol (1996) 2.07
Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke (2000) 2.05
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Overestimation of copper deficiency in horses? Vet Rec (1995) 2.03
A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature (1993) 2.03
Rats of the genus Rattus are reservoir hosts for pathogenic Bartonella species: an Old World origin for a New World disease? J Infect Dis (1999) 2.03
Nova Scotia only province to provide clinic for "environmentally sensitive" patients. CMAJ (1992) 2.01
Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain (2006) 2.00
Effects of polychlorinated biphenyls on the nervous system. Toxicol Ind Health (2000) 1.97
Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet (1997) 1.96
Reclassification of 'Corynebacterium haemolyticum' (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen.nov. as Arcanobacterium haemolyticum nom.rev., comb.nov. J Gen Microbiol (1982) 1.96
Long-distance charge transport in duplex DNA: the phonon-assisted polaron-like hopping mechanism. Proc Natl Acad Sci U S A (1999) 1.95
Issues and themes in computer aided design for external prosthetics and orthotics. J Biomed Eng (1988) 1.94
Sick hospital, sick doctor: Halifax hospital tries to cope with "environmental illness". CMAJ (1992) 1.93
Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med (1981) 1.92
Effects of external rhythmical cueing on gait in patients with Parkinson's disease: a systematic review. Clin Rehabil (2005) 1.91
Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res (2001) 1.89
A numerical taxonomic survey of Listeria and related bacteria. J Gen Microbiol (1977) 1.85
Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med (1998) 1.85
Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol (2001) 1.83
Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry (1986) 1.83
Efficacy of postoperative follow-up telephone calls for patients who underwent adenotonsillectomy. Arch Otolaryngol Head Neck Surg (2000) 1.83
Progressive language disorder due to lobar atrophy. Ann Neurol (1992) 1.82
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing. J Cell Biol (1994) 1.80
TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia (2006) 1.79
Sub-clinical entrapment neuropathy in man. J Neurol Sci (1975) 1.78
The occurrence of alpha(1-3)glucan in Cryptococcus, Schizosaccharomyces and Polyporus species, and its hydrolysis by a Streptomyces culture filtrate lysing cell walls of Cryptococcus. Biochim Biophys Acta (1968) 1.78
Cytochrome composition and effect of catalase on growth of Agromyces ramnosus. Nature (1970) 1.75
Ophthalmic manifestations of neurofibromatosis. Br J Ophthalmol (1987) 1.74
The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol Cell Biol (1994) 1.73
Taxonomic studies on some group D streptococci. J Gen Microbiol (1983) 1.73
The prevalence of faecal incontinence in older people living at home. Age Ageing (2001) 1.72
Discitis in young children. J Bone Joint Surg Br (2001) 1.72
De-functioning stomas: a prospective controlled trial comparing loop ileostomy with loop transverse colostomy. Br J Surg (1986) 1.71
Knowledge of famous faces and names in semantic dementia. Brain (2004) 1.68
Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression. Mol Cell Biol (1995) 1.67
Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol (2001) 1.65
A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Eur J Pharmacol (1995) 1.64
Nontuberculous mycobacterial infection of the head and neck in immunocompetent children: CT and MR findings. AJNR Am J Neuroradiol (2000) 1.63
Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry (1993) 1.62
Regulation of citrate synthase and microbial taxonomy. Nature (1968) 1.60
The separation of beta-glucanases produced by Cytophaga johnsonii and their role in the lysis of yeast cell walls. Biochem J (1970) 1.60
The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol (1993) 1.58
Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer (2010) 1.57
Cowpox virus infection in unusual hosts. Vet Rec (1979) 1.57
The location of chitin in the yeast cell wall. Biochem J (1966) 1.56
Has publication of the results of the ORACLE Children Study changed practice in the UK? BJOG (2010) 1.55
ARF1 mediates paxillin recruitment to focal adhesions and potentiates Rho-stimulated stress fiber formation in intact and permeabilized Swiss 3T3 fibroblasts. J Cell Biol (1998) 1.55
Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (1999) 1.55
Sports and recreation injuries in US children and adolescents. Arch Pediatr Adolesc Med (1995) 1.54
Varus and valgus deformities of the foot in cerebral palsy. Dev Med Child Neurol (1982) 1.54
Adjustments and measures of differential expression for microarray data. Bioinformatics (2002) 1.54
A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol Appl Neurobiol (1990) 1.53
Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features. Leukemia (2010) 1.51
Structure and function of proteins controlling strain-specific pathogen resistance in plants. Curr Opin Plant Biol (1998) 1.51
Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol (2002) 1.51